Showing results (21-30 of 247) with videos related to

Sort By:
Pageof 25
Inflammation|December 23, 2011
Serum levels of secreted group IIA phospholipase A(2) in benign prostatic hyperplasia and prostate cancer: a biomarker for inflammation or neoplasia?Mario Menschikowski, Albert Hagelgans, Susanne Fuessel, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|September 25, 2013
Serum amyloid A, phospholipase A₂-IIA and C-reactive protein as inflammatory biomarkers for prostate diseasesMario Menschikowski, Albert Hagelgans, Susanne Fuessel, et al.
Urology|October 16, 2010
Importance of erythrocyte band III anion transporter (SLC4A1) on oxalate clearance of calcium oxalate monohydrate stone-formering patients vs. normal controlsSven Oehlschläger, Susanne Fuessel, Axel Meye, et al.
BMC Cancer|February 13, 2014
Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAsKati Erdmann, Knut Kaulke, Cathleen Thomae, et al.
International Journal of Oncology|May 13, 2004
Quantification of disseminated tumor cells in the bloodstream of patients with hormone-refractory prostate carcinoma undergoing cytotoxic chemotherapyUta Schmidt, Udo Bilkenroth, Clemens Linné, et al.
The Journal of Urology|May 6, 2004
Systematic in vitro evaluation of survivin directed antisense oligodeoxynucleotides in bladder cancer cellsSusanne Fuessel, Bernd Kueppers, Shuangli Ning, et al.
Oncotargets and Therapy|May 17, 2014
Stage-dependent prognostic impact of molecular signatures in clear cell renal cell carcinomaThomas Weber, Matthias Meinhardt, Stefan Zastrow, et al.
Urology|December 15, 2004
Qualitative and quantitative assessment of urinary cytokeratin 8 and 18 fragments compared with voided urine cytology in diagnosis of bladder carcinomaOliver W Hakenberg, Susanne Fuessel, Katja Richter, et al.
Diagnostics (Basel, Switzerland)|August 14, 2020
Evaluation of MicroRNAs as Non-Invasive Diagnostic Markers in Urinary Cells from Patients with Suspected Prostate CancerAngelika Borkowetz, Andrea Lohse-Fischer, Jana Scholze, et al.
The Journal of Urology|June 11, 2005
Vascular endothelial growth factor antisense pretreatment of bladder cancer cells significantly enhances the cytotoxicity of mitomycin C, gemcitabine and CisplatinSabine Krause, Yvonne Förster, Kai Kraemer, et al.
Pageof 25